Current Research on Indevus Pharmaceuticals Inc.

M2 PRESSWIRE-7 June 2007-Biotech News: Current Research on Indevus Pharmaceuticals Inc(C)1994-2007 M2 COMMUNICATIONS LTD RDATE:07062007 Current Research on Indevus Pharmaceuticals Inc (NASDAQ:IDEV) Indevus Pharmaceuticals, Inc., a biopharmaceutical company, engages in the acquisition, development, and commercialization of products to treat urological, gynecological, and men's health conditions.

The company's marketed products include SANCTURA for overactive bladder, which it co-promotes with its partner Esprit Pharma, Inc., and DELATESTRYL (testosterone enanthate) for the ...

Read the rest of this article with a Free Trial at HighBeam Research.